Microbot Medical Inc. (MBOT)
NASDAQ: MBOT · Real-Time Price · USD
4.070
+0.190 (4.90%)
At close: Aug 27, 2025, 4:00 PM
4.100
+0.030 (0.74%)
After-hours: Aug 27, 2025, 7:58 PM EDT

Microbot Medical Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 20202016 - 2020
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2016 - 2020
Selling, General & Admin
6.095.224.345.775.415.89
Upgrade
Research & Development
7.396.415.517.515.953.2
Upgrade
Operating Expenses
13.4711.639.8613.2811.369.09
Upgrade
Operating Income
-13.47-11.63-9.86-13.28-11.36-9.09
Upgrade
Interest Expense
------0.08
Upgrade
Interest & Investment Income
0.450.180.230.120.04-
Upgrade
Other Non Operating Income (Expenses)
0.32-----
Upgrade
EBT Excluding Unusual Items
-12.71-11.44-9.63-13.16-11.31-9.17
Upgrade
Gain (Loss) on Sale of Assets
---0-0.01--
Upgrade
Legal Settlements
---1.11---
Upgrade
Pretax Income
-12.71-11.44-10.74-13.17-11.31-9.17
Upgrade
Net Income
-12.71-11.44-10.74-13.17-11.31-9.17
Upgrade
Net Income to Common
-12.71-11.44-10.74-13.17-11.31-9.17
Upgrade
Shares Outstanding (Basic)
251610777
Upgrade
Shares Outstanding (Diluted)
251610777
Upgrade
Shares Change (YoY)
92.97%53.38%40.49%2.14%-0.14%66.80%
Upgrade
EPS (Basic)
-0.50-0.73-1.05-1.81-1.59-1.29
Upgrade
EPS (Diluted)
-0.50-0.73-1.05-1.81-1.59-1.29
Upgrade
Free Cash Flow
-9.93-8.85-8.57-11.63-9.42-7.34
Upgrade
Free Cash Flow Per Share
-0.39-0.57-0.84-1.60-1.33-1.03
Upgrade
EBITDA
-13.4-11.53-9.75-13.18-11.28-9.02
Upgrade
D&A For EBITDA
0.080.090.110.10.080.07
Upgrade
EBIT
-13.47-11.63-9.86-13.28-11.36-9.09
Upgrade
Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q